Evidence map›Paper›PMID 36451859›Full record

ArticleTheranostics2022

Multiomic analysis for optimization of combined focal and immunotherapy protocols in murine pancreatic cancer.

James Wang, Brett Z Fite, Aris J Kare, Bo Wu, Marina Raie, Spencer K Tumbale, Nisi Zhang, Ryan R Davis, Clifford G Tepper, Sharon Aviran and 3 more

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. OMIP-095: 40-Color spectral flow cytometry delineates all major leukocyte populations in murine lymphoid tissues.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2023
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

James WangDepartment of Radiology, Stanford University, Palo Alto, CA 94305, USA.
Brett Z FiteDepartment of Radiology, Stanford University, Palo Alto, CA 94305, USA.
Aris J KareDepartment of Radiology, Stanford University, Palo Alto, CA 94305, USA.
Bo WuDepartment of Radiology, Stanford University, Palo Alto, CA 94305, USA.
Marina RaieDepartment of Radiology, Stanford University, Palo Alto, CA 94305, USA.
Spencer K TumbaleDepartment of Radiology, Stanford University, Palo Alto, CA 94305, USA.
Nisi ZhangDepartment of Radiology, Stanford University, Palo Alto, CA 94305, USA.
Ryan R DavisDepartment of Pathology and Laboratory Medicine, University of California Davis, School of Medicine, Sacramento, CA 95817, USA.
Clifford G TepperDepartment of Biochemistry and Molecular Medicine, University of California Davis, School of Medicine, Sacramento, CA 95817, USA.
Sharon AviranDepartment of Biomedical Engineering, University of California Davis, Davis, CA 95616, USA.
Aaron M NewmanInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, CA, 94305, USA.
Daniel A KingDivision of Medical Oncology/Hematology, Northwell Health Cancer Institute, New Hyde Park, NY 10042 USA.
Katherine W FerraraDepartment of Radiology, Stanford University, Palo Alto, CA 94305, USA.
Palo Alto University · USStanford University · USUniversity of California, Davis · USNorthwell Health · US

Funding

Specific and high-resolution ultrasound cancer imagingR01CA112356 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI FERRARA, KATHERINE W, FOIRET, JOSQUIN · 2005 to 2022
$6.1M
Stanford Molecular Imaging Scholars (SMIS) ProgramT32CA118681 · NCI · STANFORD UNIVERSITY · PI CRAIG S LEVIN · 2016 to 2026
$4.3M
Imaging Modulation of Immune PhenotypeR01CA250557 · NCI · STANFORD UNIVERSITY · PI FERRARA, KATHERINE W, LEVY, RONALD · 2021 to 2025
$3.2M
Image-guided ultrasound therapy and drug delivery in pancreatic cancerR01CA210553 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FERRARA, KATHERINE W · 2016 to 2020
$3.2M
HIFU-immunotherapy in pancreatic cancerR01CA253316 · NCI · STANFORD UNIVERSITY · PI FERRARA, KATHERINE W · 2020 to 2024
$3.1M
NCI NIH HHS R01 CA112356NCI NIH HHS R01 CA210553NCI NIH HHS R01 CA250557NCI NIH HHS R01 CA253316NCI NIH HHS T32 CA118681
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaPancreatic NeoplasmsAnimalsImmunologic FactorsImmunotherapyMiceTumor MicroenvironmentImmunologic FactorsCombination immunotherapyDigital cytometryFocused ultrasoundSequencingSpectral cytometry

Identifiers

PMID36451859
PMCPMC9706583
OpenAlexW4310645560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.